Originally Posted by
Tfork
https://healthfeedback.org/claimrevi...fected-people/
An excerpt:
KEY TAKE AWAY
Most people who had COVID-19 develop some level of protective immunity. However, the immune response can vary a lot between individuals, and
not all COVID-19 survivors develop sufficiently protective immunity, since reinfection can occur. COVID-19 vaccines have demonstrated a more robust and reliable immune response than natural infection. They can also provide additional benefits, such as boosting immunity in people who had a low immune response after natural infection or enhancing protection against variants of the virus.
You got THAT from the article?
I’d grant that is true, but that provides no meaningful distinction from those getting immunized who are ALSO getting subsequent infections and some who are not apparently deriving any protection - at least over the short term - from their immunizations (hence, less than 100% efficacy of ALL brands of vaccine).
Experts continue to learn about Pfizer’s efficacy both in the laboratory and in the real world. Pfizer’s initial Phase 3 clinical data presented in December showed its vaccine to have 95% efficacy.
In April,
the company announced the vaccine had 91.3% efficacy against COVID-19, based on measuring how well it prevented symptomatic COVID-19 infection seven days through up to six months after the second dose
Greater than 90% efficacy against cases of COVID-19 and more than 95% against severe cases, with approximately 6 months median follow-up after the second dose, according to the company. Earlier Phase 3 studies showed Moderna to be 94.1% effective at preventing symptomatic infection in people with no evidence of previous COVID-19 infection (although the efficacy rate drops to 86.4% for people ages 65 and older).
72% overall efficacy and 86% efficacy against severe disease in the U.S., according to analyses posted by the FDA in February. Experts are still learning about how the vaccine works in real-world conditions.
How well it works on virus mutations: Johnson & Johnson reported in July that its vaccine is also effective against the Delta variant, showing only a small drop in potency compared with its effectiveness against the original strain of the virus. Although one
recent study, which has not yet been peer-reviewed or published in a scientific journal, suggests that the J&J vaccine is less effective against Delta.
Seems like you are demanding a perfection from natural immunity that we don’t even see in immunizations. Don’t you think we should judge each by equal criteria?